Silicon Valley Cardiology
Cardiology
Dr. Roger A. Winkle, MD
|
|
Give Review
Dr. Roger A. Winkle works in the field of Cardiology. He went to University of Cincinnati College of Medicine. He received awards:"Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Top MD" and "Fellow (FACC)". Roger A. Winkle, MD has written publications. He has 100 publications published with PubMed. The lastest publication is: 'Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.' Roger Winkle accepts Medicare payments and is registered with Medicare.gov.
Publications
- Peri-procedural interrupted oral anticoagulation for Atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
- Uninterrupted Warfarin Anticoagulation for Atrial Fibrillation Ablation: Too Good to Be True?
- Atrial fibrillation ablation using open-irrigated tip RF: Experience with intraprocedural ACT ≤210 seconds.
- Discontinuing anticoagulation following successful Atrial fibrillation ablation in patients with prior strokes.
- Finding Our Way through the Maze.
- Peri-ablation warfarin vs. dabigatran: different but the same.
- Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of Atrial fibrillation ablation patients.
- Physician-controlled costs: the choice of equipment used for Atrial fibrillation ablation.
- Evolution of the Implantable Cardioverter-Defibrillator: From Bullets to BBs.
- Atrial Arrhythmia Burden on Long-Term Monitoring in Asymptomatic Patients Late After Atrial Fibrillation Ablation.
- The Use of Dabigatran Immediately After Atrial Fibrillation Ablation.
- Long-term results of Atrial fibrillation ablation: the importance of all initial ablation failures undergoing a repeat ablation.
- Relation of early termination of persistent Atrial fibrillation by cardioversion or drugs to ablation outcomes.
- The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for Atrial fibrillation ablation.
- Safety of lower activated clotting times during Atrial fibrillation ablation using open irrigated tip catheters and a single transseptal puncture.
- Atrial fibrillation ablation: "perpetual motion" of open irrigated tip catheters at 50 W is safe and improves outcomes.
- The effectiveness and cost effectiveness of public-access deFibrillation.
- Myocardial involvement in idiopathic hemochromatosis. Morphologic and clinical improvement following venesection.
- Characterization of ventricular tachyArrhythmias on ambulatory ECG recordings in post-myocardial infarction patients: arrhythmia detection and duration of recording, r...
- Current status of ambulatory electrocardiography.
- Ambulatory electrocardiography.
- The relationship between the repetitive extrasystole threshold and the ventricular Fibrillation threshold in the dog. Non-parallel changes following pharmacological in...
- Accuracy of the ventricular tachycardia-induction study for predicting long-term efficacy and inefficacy of antiarrhythmic drugs.
- Time dependency of ventricular Fibrillation thresholds determined using trains of stimuli.
- Implantable cardioverter defibrillator: Ventritex Cadence.
- Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyArrhythmias. Intravenous Amiodarone Multicenter Trial Group.
- Patterns of cognitive recovery in sudden cardiac arrest survivors: the pilot study.
- Echocardiographic evaluation of propranolol therapy for mitral Valve prolapse.
- Automatic implantable cardioverter defibrillator: surgical approaches for implantation.
- Defibrillator "twiddler's" Syndrome.
- State-of-the-art of the AICD.
- Clinical pharmacology of intravenous enoximone: pharmacodynamics and pharmacokinetics in patients with Heart failure.
- Disposition kinetics of orally administered enoximone in patients with moderate to severe Heart failure.
- Comparison of pre- and postoperative conduction patterns in patients surgically cured of atrioventricular node reentrant tachycardia.
- Early automatic implantable cardioverter-defibrillator implantation: medical and economic considerations and inequities in health care reimbursement.
- Pharmacodynamics of enoximone during intravenous infusion.
- Effect of duration of ventricular Fibrillation on deFibrillation efficacy in humans.
- Implantation of the automatic implantable cardioverter defibrillator (AICD): practical aspects.
- Nonpharmacologic therapy of tachycardias: the role of implanted devices.
- Recordings of basal ventricular preexcitation from electrode catheters in patients with accessory atrioventricular connections.
- Clinical efficacy and electrophysiology of imipramine for ventricular tachycardia.
- Measurement of cardioversion/deFibrillation thresholds in man by a truncated exponential waveform and an apical patch-superior vena caval spring electrode configuration.
- Propafenone disposition kinetics in cardiac arrhythmia.
- Amiodarone and the American Way.
- Neisseria meningitidis cellulitis.
- Tocainide for drug-resistant ventricular Arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success.
- Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular Arrhythmias.
- Malignant ventricular tachyArrhythmias associated with the use of encainide.
- Mechanisms of ventricular tachycardia: wide, complex ignorance.
- Metabolite cumulation during long-term oral encainide administration.
- Acute hemodynamic effects of intravenous encainide in patients with heart disease.
- Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
- Clinical factors predicting successful electrophysiologic-pharmacologic study in patients with ventricular tachycardia.
- Ambulatory monitoring of electrocardiograms - current technology of recording and analysis.
- Mortality in patients with implanted automatic defibrillators.
- Lorcainide disposition kinetics in arrhythmia patients.
- Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory Arrhythmias.
- Determinants of survival in patients with ventricular tachyArrhythmias.
- Safety and efficacy of intravenous quinidine.
- Comparison of the electrophysiologic effects of intravenous and oral lorcainide in patients with recurrent ventricular tachycardia.
- Prognostic significance of the number of induced ventricular complexes during assessment of therapy for ventricular tachyArrhythmias.
- The automatic implantable defibrillator: local ventricular bipolar sensing to detect ventricular tachycardia and Fibrillation.
- Clinical pharmacology of propafenone.
- Relative efficacy of blind left ventricular Aneurysm resection for the treatment of recurrent ventricular tachycardia.
- Clinical efficacy of antiarrhythmic drugs in prevention of sudden Coronary death.
- Ambulatory electrocardiography and the diagnosis, evaluation, and treatment of chronic ventricular Arrhythmias.
- Randomized double-blind placebo controlled crossover trial documenting oral lorcainide efficacy in suppression of symptomatic ventricular tachyArrhythmias.
- Frequency response characteristics of ambulatory ECG monitoring systems and their implications for ST segment analysis.
- Programmed ventricular stimulation in predicting vulnerability to ventricular Arrhythmias and their response to antiarrhythmic therapy.
- Surgery for ventricular tachycardia: efficacy of left ventricular Aneurysm resection compared with operation guided by electrical activation mapping.
- The relationship between ventricular ectopic beat frequency and Heart rate.
- Decreased incidence of antiarrhythmic drug efficacy at electrophysiologic study associated with the use of a third extrastimulus.
- Beta blockers in the treatment of Acute arrhythmias [proceedings].
- Suppression of premature ventricular contractions by acebutolol.
- Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.
- Surgical management of life-threatening ventricular arrhythmias in patients with Coronary artery disease.
- The electrophysiologic effects of quinidine in the transplanted human Heart.
- Hemodynamic effects of intravenously administered quinidine on the transplanted human Heart.
- Clinical pharmacokinetics of antiarrhythmic drugs.
- Electrophysiological effects of acebutolol.
- Contribution of ambulatory electrocardiographic monitoring to antiarrhythmic management.
- Continuing disability of patients with chest pain and normal Coronary arteriograms.
- Role of concentration-dependent plasma protein binding in disopyramide disposition.
- Measuring antiarrhythmic drug efficacy by suppression of asymptomatic ventricular Arrhythmias.
- Characteristics of ventricular tachycardia in ambulatory patients.
- Clinical electrophysiologic effects of tocainide.
- The hemodynamic effects of intravenous tocainide in patients with heart Disease.
- Long-term tocainide therapy for ventricular Arrhythmias.
- Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy.
- Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
- Effects of tocainide on ventricular Fibrillation threshold. Comparison with lidocaine.
- Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainami...
- Cardiac biopsy evidence for a cardiomyopathy associated with symptomatic mitral Valve prolapse.
- Dose-dependent acebutolol disposition after oral administration.
- Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
- Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.
- Propranolol for patients with mitral Valve prolapse.
- Response optimization of drug dosage: antiarrhythmic studies with tocainide.
- Benign slow paroxysmal Atrial tachycardia.
Schools
University Of Cincinnati College Of Medicine
Barnes Jewish Hospital
Stanford University
Cornell University
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
- Clinical Cardiac Electrophysiology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Top MD
- Fellow (FACC)
Education
-
Washington University - Barnes-Jewish Hospital -
University of Cincinnati College of Medicine
Hospital
-
Santa Clara Valley Medical Center -
Sequoia Hospital -
Stanford Health Care
Drug Facts
| NPI NUMBER | 1700810330 | |
| NPPES Provider LastName | WINKLE | |
| NPPES Provider FirstName | ROGER | |
| NPPES Provider ZIPCode | 943032250 | |
| NPPES Provider State | CA | |
| Specialty Description | Cardiac Electrophysiology | |
| Total Claim Count | 4150.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700810330 |
| Last Name Of The Provider | WINKLE |
| First Name Of The Provider | ROGER |
| View All |
Similar Doctors
|
Dr. Rob A. Patrawala, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert H. Mead, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael A. Ruder, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward T. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Donald A. St Claire Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nellis A. Smith, MD |
|
Dr. Melissa H. Kong, MD
This Doctor is OpenDoctor Recommended.
|